Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
A dual memoir, published in 2009, by Dr. Michael Lockshin, and patient Alida Brill, on their long-time relationship, dealing with chronic illness. An invaluable resource for MDs and…
NEW YORK (Reuters Health) – In men with diabetes, coffee consumption does not increase the risk of cardiovascular diseases or all-cause morality, according to a brief report in…
NEW YORK (Reuters Health) – In patients with chronic stroke and impaired hand movements, electrical somatosensory stimulation (ESS) of the median nerve of the affected hand appears to…
NEW YORK (Reuters Health) – Rituximab (Rituxan) has been implicated in 57 cases of progressive multifocal leukoencephalopathy (PML) in HIV-negative patients diagnosed with hematologic malignancies or autoimmune diseases,…
NEW YORK (Reuters Health) – Basic clinical information can identify individuals at high risk of developing diabetes within 10 years, and adding some lab values identifies those at…
NEW YORK (Reuters Health) – Consistent with some previous reports, the results of a case-control study suggest that depressive symptoms are an early feature of Parkinson’s disease, preceding…
NEW YORK (Reuters Health) – Even though most surviving preterm infants with periventricular hemorrhagic infarction (PVHI) have cerebral palsy, results of a prospective cohort study indicate that functional…
On April 22nd-23rd, 2009 in Boston, MA Health 2.0 and the Center for Information Therapy hosted its first joint conference.Health 2.0 is the ground breaking conference that showcases…
NEW YORK (Reuters Health) – Herd immunity is not enough to protect unvaccinated children against pertussis. A case-control study based on detailed, individual-level clinical data indicates that children…
NEW YORK (Reuters Health) – Combining hepatic artery infusion of floxuridine/dexamethasone with systemic oxaliplatin and irinotecan can make liver metastases from colorectal cancer resectable in about half of…
